NORTHWEST BIOTHERAPEUTICS INC Common Stock

YTD

ALL

Why Robinhood?

You can watch NWBO and buy or sell other stocks, ETFs, and their options commission-free!

About NWBO

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer.

CEO

Linda F. Powers

CEOLinda F. Powers

Employees

Employees25

Headquarters

Bethesda, Maryland

HeadquartersBethesda, Maryland

Founded

1996

Founded1996

Employees

Employees25

NWBO Key Statistics

Market cap

380.50M

Market cap380.50M

Price-Earnings ratio

-3.90

Price-Earnings ratio-3.90

Dividend yield

—

Dividend yield—

Average volume

2.08M

Average volume2.08M

High today

—

High today—

Low today

—

Low today—

Open price

$0.275

Open price$0.275

Volume

0.00

Volume0.00

52 Week high

$0.4977

52 Week high$0.4977

52 Week low

$0.1685

52 Week low$0.1685

NORTHWEST BIOTHERAPEUTICS INC Common Stock

Why Robinhood?

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. Show more

NWBO Key Statistics

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer.